Neurocrine Biosciences Inc

Clearbridge Investments, LLC NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

310,077

Value ($000)

43,978

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	43,978	0.0%	310,077	12/31/2025
2025 Q3	11/13/2025	47,299	0.0%	336,936	9/30/2025
2025 Q2	8/12/2025	43,024	0.0%	342,302	6/30/2025
2025 Q1	5/13/2025	37,859	0.0%	342,302	3/31/2025
2024 Q4	2/12/2025	43,584	0.0%	319,299	12/31/2024
2024 Q3	11/12/2024	36,790	0.0%	319,299	9/30/2024
2024 Q2	8/27/2024	46,918	0.0%	340,802	6/30/2024
2024 Q1	5/13/2024	47,003	0.0%	340,802	3/31/2024
2023 Q4	2/9/2024	44,904	0.0%	340,802	12/31/2023
2023 Q3	11/13/2023	35,100	0.0%	311,997	9/30/2023
2023 Q2	8/11/2023	29,421	0.0%	311,997	6/30/2023
2023 Q1	5/12/2023	25,385	0.0%	250,787	3/31/2023
2022 Q4	2/10/2023	29,954	0.0%	250,787	12/31/2022
2022 Q3	11/14/2022	26,636	0.0%	250,787	9/30/2022
2022 Q2	8/11/2022	24,447	0.0%	250,787	6/30/2022
2022 Q1	5/13/2022	23,512	0.0%	250,792	3/31/2022
2021 Q4	2/11/2022	21,360	0.0%	250,792	12/31/2021
2021 Q3	11/12/2021	24,155	0.0%	251,850	9/30/2021
2021 Q2	8/13/2021	24,515	0.0%	251,900	6/30/2021
2021 Q1	5/13/2021	24,501	0.0%	251,940	3/31/2021
2020 Q4	2/10/2021	20,275	0.0%	211,530	12/31/2020
2020 Q3	11/12/2020	21,107	0.0%	219,500	9/30/2020